Results of the phase III trials with Imagent® GI as an oral magnetic resonance contrast agent

R. F. Mattrey; M. A. Trambert; J. J. Brown; J. N. Bruneton; S. W. Young; G. L. Schooley

doi:10.1097/00004424-199111001-00021

Results of the phase III trials with Imagent® GI as an oral magnetic resonance contrast agent

R. F. Mattrey, M. A. Trambert, J. J. Brown, J. N. Bruneton, S. W. Young, G. L. Schooley

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S65-S66
Journal	Investigative Radiology
Volume	26
Issue number	SUPPL. I
DOIs	https://doi.org/10.1097/00004424-199111001-00021
State	Published - Jan 1 1991

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1097/00004424-199111001-00021

Cite this

@article{6f76791f3b6c41bd80dcdb72e885f0fd,

title = "Results of the phase III trials with Imagent{\textregistered} GI as an oral magnetic resonance contrast agent",

author = "Mattrey, {R. F.} and Trambert, {M. A.} and Brown, {J. J.} and Bruneton, {J. N.} and Young, {S. W.} and Schooley, {G. L.}",

year = "1991",

month = jan,

day = "1",

doi = "10.1097/00004424-199111001-00021",

language = "English (US)",

volume = "26",

pages = "S65--S66",

journal = "Investigative Radiology",

issn = "0020-9996",

publisher = "Lippincott Williams and Wilkins",

number = "SUPPL. I",

}

TY - JOUR

T1 - Results of the phase III trials with Imagent® GI as an oral magnetic resonance contrast agent

AU - Mattrey, R. F.

AU - Trambert, M. A.

AU - Brown, J. J.

AU - Bruneton, J. N.

AU - Young, S. W.

AU - Schooley, G. L.

PY - 1991/1/1

Y1 - 1991/1/1

UR - http://www.scopus.com/inward/record.url?scp=0025838838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025838838&partnerID=8YFLogxK

U2 - 10.1097/00004424-199111001-00021

DO - 10.1097/00004424-199111001-00021

M3 - Article

C2 - 1808151

AN - SCOPUS:0025838838

SN - 0020-9996

VL - 26

SP - S65-S66

JO - Investigative Radiology

JF - Investigative Radiology

IS - SUPPL. I

ER -

Results of the phase III trials with Imagent® GI as an oral magnetic resonance contrast agent

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this